16
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Randomized Phase II Study of a Combination of Cisplatin (DDP), 5-Fluorouracil (5-FU), and Allopurinol (HPP) Versus 5-FU in Advanced Colorectal Carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study

, , , , , , , , & show all
Pages 471-475 | Published online: 11 Jun 2009

References

  • Schwartz P R, Handschumacher R E. Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro. Cancer Res 1979; 39: 3095, 3101
  • Fox R M, Woods R L, Tattersall M HN, et al. Allopurinol modulation of fluorouracil toxicity. Cancer Chemother Pharmacol 1981; 5: 151–155
  • Howell S B, Wung W E, Taetle R. Modulation of 5-fluorouracil toxicity by allopurinol in man. Cancer 1981; 48: 1281–1289
  • Schabel F M, Trader M W, Laster W R, et al. Cis-dichlorodiammineplatinum (II): Combination chemotherapy and cross-resistance studies with tumor of mice. Cancer Treat Rep 1979; 63: 1459–1473
  • Kish J, Drelichman A, Jacobs J, et al. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of head and neck. Cancer Treat Rep 1982; 66: 471–474
  • Hellerstein S, Rosen S, Kies M, et al. Diamminedichloroplatinum and 5-fluorouracil combined chemotherapy of epidermoid esophageal cancer (abstr). Proc Am Soc Clin Oncol 1983; 2: 127
  • Einhorn L H, Williams S D, Loehrer P J. Combination chemotherapy with platinum (P) plus 5-FU in metastatic colorectal carcinoma (abstr). Proc Am Soc Clin Oncol 1984; 3: 133
  • Vanderlinden B, Rozencweig M, Tagnon A, et al. Phase I-II study with a combination of cisplatin (C) and fluorouracil (FU) with or without allopurinol (A). Proc 2nd European Conference on Clinical Oncology and Cancer Nursing, Brussels, 1983, 65
  • World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. WHO, Geneva 1979, no. 48
  • Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457–481
  • Loehrer P J, Turner S, Kubilis P, et al. A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of colorectal cancer. A Hoosier Oncology Group Trial. J Clin Oncol 1988; 6: 642–648
  • Weiss H D, Walker M D, Wiernik P H. Neurotoxicity of commonly used antineoplastic agents. N Engl J Med 1974; 291: 75–81
  • Mead G M, Arnold A M, Green J A, et al. Epileptic seizures associated with cisplatin administration. Cancer Treat Rep 1982; 66: 1719–1722
  • Burger A J, Mannino S, Huntington M D, et al. 5-Fluorouracil-induced coronary vasospasm. Am Heart J 1987; 114: 433–436
  • Doll D C, List A F, Greco F A, et al. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ cell tumors of the testis. Ann Intern Med 1984; 105: 48–51
  • Rosenfeld C S, Broder L E. Cisplatin-induced autonomic neuropathy. Cancer Treat Rep 1984; 68: 659–660
  • Turlapaty F D, Altura B M. Magnesium deficiency produces spasm of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980; 208: 198–200

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.